Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $1.65M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.63% less ownership
Funds ownership: 9.06% → 8.43% (-0.63%)
12% less capital inflows, than outflows
Capital inflows: $1.11M | Capital outflows: $1.25M
13% less funds holding
Funds holding: 31 → 27 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$861K |
| 2 |
JC
JBF Capital
Aspen,
Colorado
|
+$132K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$28K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$23.9K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.02M |
| 2 |
AIP
ARS Investment Partners
New York
|
-$61K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$48K |
| 4 |
Royce & Associates
New York
|
-$41K |
| 5 |
Morgan Stanley
New York
|
-$34.7K |
CORV Hedge Fund Activity: Q1 2020 in Review
27 of the 4,549 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2020, worth a combined $1.65M — down 12% from $1.87M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CORV and 4 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $861K. The largest seller was Tamarack Advisers, exiting entirely with an estimated $1.02M sold.
- 27 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2020, down from 31 in Q4 2019.
- Funds reported $1.65M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2020, down 12% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2020 and 7 closed out, a net change of -3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2020 was Beryl Capital Management, an estimated $861K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2020 was Tamarack Advisers, an estimated $1.02M sold.
Based on aggregated 13F filings for Q1 2020.